{
    "clinical_study": {
        "@rank": "58705", 
        "arm_group": [
            {
                "arm_group_label": "TNF-Kinoid", 
                "arm_group_type": "Experimental", 
                "description": "TNF Kinoid + ISA51"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Placebo + ISA51"
            }
        ], 
        "brief_summary": {
            "textblock": "The safety and immunogenicity of the TNF-Kinoid (TNF-K) have been evaluated in a phase II\n      clinical study conducted in subjects with Rheumatoid arthritis. Preliminary results of\n      clinical efficacy are promising.\n\n      The principal aim of the present study is to confirm the clinical efficacy of the TNF-K in\n      subjects with Rheumatoid arthritis in whom treatment with methotrexate is not working\n      anymore. Subjects who have never been treated with anti-TNF\u03b1 monoclonal antibodies will be\n      enrolled in this trial. In addition, the immune responses and the safety elicited by TNF-K\n      will also be evaluated."
        }, 
        "brief_title": "Clinical Efficacy of TNF-Kinoid in Patients With Rheumatoid Arthritis", 
        "condition": "Rheumatoid Arthritis", 
        "condition_browse": {
            "mesh_term": [
                "Arthritis", 
                "Arthritis, Rheumatoid"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Has had a diagnosis of RA according to the revised ACR criteria (Aletaha et al. 2010)\n             for at least 6 months.\n\n          -  Has been treated with and tolerated MTX  for at least 3 months prior to the first\n             administration of study product, - Has at least four swollen joints/66 and/or four\n             tender joints/68,\n\n          -  Has CRP \u2265 10 mg/L at screening.\n\n          -  Is positive for rheumatoid factor (RF) or anti-cyclic citrullinated peptides (CCP)\n             antibodies at screening.\n\n        Exclusion Criteria:\n\n          -  Has inflammatory rheumatic disease other than RA\n\n          -  Has been treated with non-biological DMARDs/systemic immunosuppressives\n\n          -  Has been treated with leflunomide within 12 weeks prior to first administration of\n             study product.\n\n          -  Has received intra-articular, intramuscular (IM), or intravenous (IV) corticosteroids\n\n          -  Has received infliximab, etanercept, adalimumab, certolizumab, golimumab; another\n             TNF\u03b1 antagonist; or rituximab prior to the study.\n\n          -  Has been treated with any other biological DMARDs"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "140", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01911234", 
            "org_study_id": "TNF-K-006", 
            "secondary_id": "2013-001999-38"
        }, 
        "intervention": {
            "arm_group_label": "TNF-Kinoid", 
            "intervention_name": "TNF-Kinoid", 
            "intervention_type": "Biological"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 11, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Brussels", 
                        "country": "Belgium", 
                        "zip": "1200"
                    }, 
                    "name": "Cliniques Universitaires Saint Luc"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tbilisi", 
                        "country": "Georgia"
                    }, 
                    "name": "\"Acad. V. Tsitlanadze Scientific-Practical Center of Rheumatology\" LLC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tbilisi", 
                        "country": "Georgia"
                    }, 
                    "name": "Tbilisi Heart and Vascular Clinic LTD"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tbilisi", 
                        "country": "Georgia"
                    }, 
                    "name": "Diagnostic services LTD"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tbilisi", 
                        "country": "Georgia"
                    }, 
                    "name": "\"Medi Club Georgia\" LLC"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hatyan", 
                        "country": "Hungary"
                    }, 
                    "name": "BKS Research Kft. Albert Schweitzer K\u00f3rhaz es Rendel\u0151intezet-3. emelet"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Szikszo", 
                        "country": "Hungary"
                    }, 
                    "name": "CRU Hungary Kft."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Veszpr\u00e9m", 
                        "country": "Hungary"
                    }, 
                    "name": "Csolnoky Ferenc K\u00f3rh\u00e1z"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Achrafieh", 
                        "country": "Lebanon"
                    }, 
                    "name": "University Medical Center Rizk Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chouf", 
                        "country": "Lebanon"
                    }, 
                    "name": "Ain Wazein Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saida", 
                        "country": "Lebanon"
                    }, 
                    "name": "Hammoud Hospital Univeristy Medical Center"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Skopje", 
                        "country": "Macedonia, The Former Yugoslav Republic of"
                    }, 
                    "name": "University Clinic of Rheumatology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chisinau", 
                        "country": "Moldova, Republic of"
                    }, 
                    "name": "IMSP Institutul de Cardiologie"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Bialystok", 
                        "country": "Poland"
                    }, 
                    "name": "Osteomedic Sc"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Krak\u00f3w", 
                        "country": "Poland"
                    }, 
                    "name": "NZOZ \"DOBRY LEKARZ\" Specjalistyczne Poradnie Lekarskie"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pozna\u0144", 
                        "country": "Poland"
                    }, 
                    "name": "Centrum Bada\u0144 Klinicznych SC."
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Ivanovo", 
                        "country": "Russian Federation"
                    }, 
                    "name": "Municipal Clinical Hospital #4"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kemerovo", 
                        "country": "Russian Federation"
                    }, 
                    "name": "Regional Clinical Hospital for War Veterans"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Saratov", 
                        "country": "Russian Federation"
                    }, 
                    "name": "City Clinical Hospital n.a.S.R.Mirotvortcev"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Yaroslavl", 
                        "country": "Russian Federation"
                    }, 
                    "name": "Clinical Hospital for Emergency Care n.a. N.V.Solovyev"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Belgrade", 
                        "country": "Serbia"
                    }, 
                    "name": "Institute of Rheumatology"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Niska Banja", 
                        "country": "Serbia"
                    }, 
                    "name": "Institute for treatment and rehabilitation \"Niska Banja\"-Nis"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Donetsk", 
                        "country": "Ukraine"
                    }, 
                    "name": "Gusak Institute of Urgent and Recovery Surgery of AMSU"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Donetsk", 
                        "country": "Ukraine"
                    }, 
                    "name": "Donetsk City Clinical Hospital #5"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kharkiv", 
                        "country": "Ukraine"
                    }, 
                    "name": "Municipal Health Care Institution \"Kharkiv City Clinical Hospital #8\""
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kyiv", 
                        "country": "Ukraine"
                    }, 
                    "name": "Kyiv Out-patient hospital #2 of Shevchenko District"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kyiv", 
                        "country": "Ukraine"
                    }, 
                    "name": "National medical academy of postgraduate education, Kiev regional clinical hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Simferopol", 
                        "country": "Ukraine"
                    }, 
                    "name": "The Seventh Simferopol City Clinical Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zaporizhzhya", 
                        "country": "Ukraine"
                    }, 
                    "name": "Municipal Institution \"Central Hospital of Ordzhonikidze District\""
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zaporizhzhya", 
                        "country": "Ukraine"
                    }, 
                    "name": "State Institution \"Departmental Clinical Hospital of Railway Station Zaporizhzhya-2\" of the State Enterprise \"Prydniprovska Zaliznytsya\""
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zhitomir", 
                        "country": "Ukraine"
                    }, 
                    "name": "Zhitomir Regional Clinical Hospital named after O.F. Herbachevskogo"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "Czech Republic", 
                "Georgia", 
                "Hungary", 
                "Lebanon", 
                "Macedonia, The Former Yugoslav Republic of", 
                "Moldova, Republic of", 
                "Poland", 
                "Russian Federation", 
                "Serbia", 
                "Ukraine"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "A Phase II, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Clinical Efficacy of Neovacs' TNF-Kinoid in Adult Subjects With Active Rheumatoid Arthritis Despite Methotrexate Therapy", 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "Belgium: Federal Agency for Medicines and Health Products, FAMHP", 
                "Czech Republic: State Institute for Drug Control", 
                "Georgia: Ministry of Health", 
                "Hungary: National Institute of Pharmacy", 
                "Lebanon: Institutional Review Board", 
                "Macedonia: Ministry of Health", 
                "Moldova: Medicines Agency", 
                "Poland: Ministry of Health", 
                "Russia: Ministry of Health of the Russian Federation", 
                "Serbia: Medicines and Medical Devices Agency", 
                "Ukraine: Ministry of Health"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "September 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Change in DAS28-CRP between Month 6 and baseline.", 
            "safety_issue": "No", 
            "time_frame": "Month 6"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01911234"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Clinical responses defined as ACR20, ACR50, ACR70, SDAI, EULAR responses, changes in Tender and Swollen joint counts, DAS-28 and HAD-QI versus baseline", 
                "safety_issue": "No", 
                "time_frame": "Several timepoints during 24 weeks study period"
            }, 
            {
                "measure": "Immunogenicity: Anti-TNF\u03b1 antibodies, Anti-TNF\u03b1 neutralizing antibody activity, Anti-KLH antibodies by ELISA ; cytokines", 
                "safety_issue": "No", 
                "time_frame": "Several timepoints during 24 weeks study period"
            }, 
            {
                "measure": "Safety assessments will be conducted throughout the study and will include physical examinations, vital signs, clinical laboratory evaluations, and the recording of adverse events (AEs)", 
                "safety_issue": "Yes", 
                "time_frame": "Several timepoints during 24 weeks study period"
            }
        ], 
        "source": "Neovacs", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Neovacs", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "September 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}